Preference, Patient
8
1
2
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
17%
1 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (8)
Preferences of Vaccination for COVID-19 Among University Students and Staff: A Discrete Choice Experiment
Preferences of Patients Treated With Oral Cancer Drugs and Informal Caregivers for Pharmaceutical Consultation in Hospital
Patient Preferences in Empathetic Communication by AI vs Human Authorship
Patient Preferences on Same-day Bilateral Intravitreal Dexamethasone Injections
Needs and Preferences of Patients With Head-neck Cutaneous SCC
Pneumococcal Nasopharyngeal and Oropharyngeal Carriage in Adults
Preferences About Personal Protective Equipment
Oral Epithelial Dysplasia Informational Needs Questionnaire